NovaBay Pharmaceuticals SG&A Expense (TTM) Analysis

NovaBay Pharmaceuticals Inc (NBY)

0.71 -0.02 (-2.74%) USD | NYAM | Sep 27, 16:00

0.6825 -0.03 (-3.87%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
June 30, 2024	11.53M
March 31, 2024	11.67M
December 31, 2023	11.26M
September 30, 2023	13.02M
June 30, 2023	12.87M
March 31, 2023	14.05M
December 31, 2022	15.29M
September 30, 2022	15.77M
June 30, 2022	16.81M
March 31, 2022	16.22M
December 31, 2021	14.92M
September 30, 2021	12.85M
June 30, 2021	12.59M
March 31, 2021	12.14M
December 31, 2020	12.10M
September 30, 2020	12.64M
June 30, 2020	11.94M
March 31, 2020	11.78M
December 31, 2019	14.08M
September 30, 2019	15.43M
June 30, 2019	17.13M
March 31, 2019	18.74M
December 31, 2018	18.62M
September 30, 2018	18.73M
June 30, 2018	19.76M

Date	Value
March 31, 2018	20.54M
December 31, 2017	22.35M
September 30, 2017	22.69M
June 30, 2017	22.01M
March 31, 2017	21.05M
December 31, 2016	19.04M
September 30, 2016	19.99M
June 30, 2016	19.78M
March 31, 2016	19.89M
December 31, 2015	18.53M
September 30, 2015	15.16M
June 30, 2015	12.35M
March 31, 2015	9.748M
December 31, 2014	7.988M
September 30, 2014	6.531M
June 30, 2014	6.145M
March 31, 2014	6.537M
December 31, 2013	6.389M
September 30, 2013	6.958M
June 30, 2013	6.667M
March 31, 2013	5.99M
December 31, 2012	5.971M
September 30, 2012	5.642M
June 30, 2012	5.505M
March 31, 2012	5.455M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

11.26M

Minimum

Dec 2023

16.81M

Maximum

Jun 2022

13.45M

Average

12.86M

Median

SG&A Expense (TTM) Benchmarks